Although Kaposi's sarcoma (KS) gene expression profile is closer to lymphatic (LEC) rather than blood vascular endothelial cells (BEC), uncertainty still surrounds the cellular origin of KS. To follow KS progression from early to late (nodular) stage, and characterize the molecular fingerprinting associated with each stage, gene arrays were used to compare gene expression profile of 9 skin samples of classic KS (4 Early, 2 Mixed, and 3 Nodular CKS samples) to 4 normal samples. Results for selected genes were validated by Real-time (RT) PCR and immunohistochemistry. Genes regulating immune and defense responses, angiogenesis, apoptosis and proliferation were differentially expressed in different KS stages compared to normal skin. Hierarchical clustering separated normal skin from KS with a clear gradient from early to nodular KS lesions. The gene expression level of endothelium markers, metalloproteinases, angiogenic factors and chemokines, gradually increased from normal through all KS stages. The expression of LEC genes highly increased from early to nodular KS. In the initiation phase we noticed a higher expression of growth factors, as compared to progressive stages. LEC and BEC markers co-exist in "KS expression signature", although the LEC signature prevailed. Our results also show a complex environment of inflammatory cells and chemokines during KS evolution. A pathogenic hypothesis where cellular hyperproliferation is driven by local expression of chemokines and growth factors without clonal expansion of cells is suggested.
Iy (patch), mixed (plaque) and late (nodular). While all tumors from all variants of KS are invariably infected with Kaposi's sarcoma-associated herpesvirus (KSHV), much curiosity has surrounded the cellular origin and malignant nature ofthe spindle cells, in particular in view of their lack of tumorigenicity or clonality (2) (3) (4) (5) (6) . In spite of a possible cellular heterogeneity of the spindle cells population, most researchers have implied that KS spindle cells express markers characteristic of endothelial lineage (7) (8) (9) (10) . Recent studies favored a lymphatic endothelial cell (LEC), rather than blood vascular endothelial cell (BEC), origin of KS spindle cells (10) (11) (12) , while virally encoded mi-croRNAs were shown to playa role in maintaining the differentiation status of LECs (13) . Discovery of LEC marker proteins (specifically podoplanin and LYVE-I) has allowed defining human LEC and BEC-specific transcriptomes (14) . KSHV infection of BECs was hypothesized to induce differentiation to LECs as they transform into spindle cells (1O, 15) . Nevertheless, the precise histogenesis of KS lesions and genomic factors involved in the initiation and propagation of the disease have not been clarified. Moreover, the exact role ofKSHV infection in the cellular reprogramming events that occur at the initiation and progression of the disease through its different stages has not yet been evaluated.
The present study followed the progression of KS disease from early to nodular stage, characterizing the molecular fingerprinting of KS lesions associated with the different stages ofthe disease. We characterized "KS cluster" genes and followed the changes in their expression level by stage. In general, increased expression of "KS cluster" genes was observed from early to the nodular stage. In comparison to both normal skin and early KS the mixed and nodular KS showed a dramatic increase in the expression of both LEC and immunerelated genes. A striking similarity was found in gene expression of mixed and nodular stages, in accordance with the histologic difficulty to distinguish between these stages. An abundance of cytokine and chemokine immune regulators was noticed in the gene signature of KS, particularly in the mixed and nodular stages. 
MATERIALS AND METHODS

Study design and skin samples
Sample preparation for gene chip analysis
All experiments were performed using Affymetrix Hul33A2 Human Focus oligonucleotide arrays, as previously described (16). Briefly, 5 ug of mRNA was used to generate first-strand cDNA. After second-strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP (Enzo Diagnostics). The target cDNA generated was processed per manufacturer's recommendation (17) . When scaled to a target intensity of 150 [using Affymetrix Microarray Suite 5 (MAS 5) array analysis software], scaling factors for all arrays were within acceptable limits (1.07-2.08), as were background, Q values and mean intensities. Details of quality control measures can be found at http://www.ncbi.nlm.nih.gov/ geo/ or at http://eng.sheba.co.il/genomics.
DNA microarray analysis
The 8757 probe sets contained in the Affymetrix Human Focus oligonucleotide array were filtered using MAS 5 array analysis software (Affymetrix Inc). A list of 5380 "valid" probe sets, representing probe sets with signals higher than 20 and detected as present (P) in at least one sample was obtained. Diseased and control samples were compared at each time point.
The comparison generated a list of 612 "active genes" representing probe sets changed by at least 2-fold as calculated from the MAS 5 Log Ratio values (LR>=1 or LR<=-l) and detected as "Increased" or as "Decrease" (lor 0, p-value 0.0025) or "Marginal Increased" or as "Marginal Decreased" (MI or MD, p-value 0.003) in all diseased samples as compared to all control samples. This list excluded genes with signals lower than 20 or detected as absent. Detailed protocols for data analysis were previously described (18) .
Gene expression analysis using GeneSpring (Silicon Genetics, Redwood City, CA, USA) 7.0, RMA (Robust Multi-Chip Average) algorithm was applied, as described elsewhere (18) . Hierarchical clustering was performed using GeneSpring 7.0 as previously described (18) . Genes with a similar pattern of expression were grouped together as hierarchical clusters and presented as heatmaps (18) .
Statistical comparisons
Data were analyzed by unpaired 2-tailed or I-tailed t-test. Genes that passed the Benjamini & Hoechberg correction were considered as most relevant. An associated probability of < 0.05 was considered significant.
Description ofrelevant functions ofgene
GeneOntology annotations of differentially expressed genes were collected from LocusLink (19) .
Real time res analysis
The primers and probes for TaqMan RT-PCR assays were designed by Applied Biosystems (Foster City, California): MMPl (Assay ID Hs00233958), MMP2 (Assay ID Hs00234422), MMP9 (Assay ID Hs00234579), LYVE-l (Assay ID Hs00272659), Angiopoietin 2 (Assay ID HsOOl69867), PROXl (Assay ID HsOOl60463), VEGF-C (Assay ID HsOOI53458), Podoplanin (Assay ID Hs00362718), IGFI (Assay ID HsOOI53126), CD36 (Assay ID HsOOl69627), CDl63 (Assay ID HsI74705), CXCL9 (Assay ID HsOOI71065), CXCLll (Assay ID 00171138). RT-PCR reactions were performed using EZ PCR Core Reagents (Applied Biosystems) as previously reportedl6. The human acidic ribosomal protein (hARP) gene, was used to normalize each sample and each gene with the following primers: HARP-forward CGCTGCTGAACATGCTCAA, HARP-reverse TGTC-GAACACCTGCTGGATG, HARP-probe 6-FAM-TCCCCCTTCTCCTTTGGGCTGG-TAMRA (Gene Bank Accession Number NM-001002). Data were analyzed Applied Biosystems PRISM 7700 (Sequence Detection Systems, ver.l.7). Statistical comparisons were performed using a 2-tailed t-test, with a probability of < 0.05 considered significant.
Immunohistochemistry and immunoflouresence
Cryostat tissue sections were stained with haematoxylin (Fisher, Fair Lawn, NJ, USA) and eosin (Shandon, Pittsburgh, PA, USA) (H&E). For immunohistochemistry purified mouse anti-human monoclonal antibodies were used to the following proteins: CDllc (BD PharMingen), CD206 (Gene Tex), LYVE-l (R&D Systems), Tie-2 (R&D Systems), PROXI (R&D Systems), KSHV (Gene Tex), MMPI (Abeam, Cambridge, MA, USA), MMP9 (Abeam, Cambridge, MA, USA), CDl63 (Serotec), and HLA-DR (Abeam, Cambridge, MA, USA, USA) was amplified with avidin-biotin complex (Vector Laboratories) and developed with chromogen 3-amino-9-ethyicarbazole (Sigma Aldrich). For immunoflouresence, skin sections were fixed with acetone, blocked in 10% normal goat serum (Vector Laboratories), incubated overnight at 4°C and stained with an anti-isotype antibody conjugated to a fluorochrome and blocked with 10% mouse serum. A second primary antibody was applied, and detected with an anti-isotype antibody conjugated to an alternate fluorochrome. Images were acquired by a Zeiss Axioplan 21 upright microscope with attached Zeiss 5 Fluar/0.25 and 10 Fluar/0.05 lenses.
RESULTS
KS cluster genes followed by stage
Hierarchical clustering of the DNA microarray data by similarities in the expression profile, as previously described (20) , allowed us to define a "KS signature" and to follow the changes in gene expression by the stage of the disease (Fig. 1 ). This revealed a striking similarity in the signature of the disease between mixed and nodular stages, though a higher signal of expression was observed in the nodular stage. In contrast with the advanced stages of the disease, the transcription profile of early KS was only modestly different than normal skin. The microarray data was further confirmed for selected genes by real-time RT-PCR ( Fig. 2 ) and immunohistochemical staining ( Fig. 3a ), using all nine KS and four normal samples. We identified several classes of genes differently expressed in the various stages of KS in comparison with normal skin. These included genes regulating host immune and cell-defense responses (e.g. CXCL9, CXCLlO, CXCR4 and CIQA), apoptosis (e.g. TOSO), proliferation (e.g. IGFl) and invasion (MMP9, MMP2). Among the immune response genes, there were many genes representing different cell types participating in immune responses, including T-cells (e.g CD2, granzyme A (GZMA) and K (GZMK), BI plasma cells (i.e immunoglobulin genes), monocytes (CD14) and macrophages (CD163). Interestingly, we noticed a steep rise in the transcription levels of the immunoglobulin lambda joining 3 (IGLB) and the IgG1 heavy chain (IGHG 1) constant region genes with stages of KS. These genes are traditionally thought to be produced by differentiated B lymphocytes, however IGHG 1 has been recently found to be expressed in non-hematopoietic human cancer cells (21) .
Several chemokines, including CXCL9, CXCLl 0, CXCLll and CCL5 and the chemokine receptors CXCR4 and CCRl, were upregulated in all 3 stages in our KS transcriptome, with a very high expression in the nodular stage, (p< 0.05) (Fig. 1) .
The gene expression level of the monocytic marker CD 14 and the macrophage marker CD163 was remarkably increased in the advanced stages of the disease, with only a mild increase in early stage KS (Fig. 1 ). CD 163 mRNA expression was gradually up-regulated from normal skin through early to advanced KS, as determined by RT-PCR analysis (Fig. 2) . Immunohistochemistry was performed to further verify the protein expression of the macrophage markers CD163 and HLA-DR. Interestingly, both CD163 and HLA-DR showed a more intense distribution in early stage KS than in the nodular stage. Staining for the myeloid dendritic cell marker CD 11 c+ showed a similar distribution in the early and late stages, though higher intensity was noticed in the nodular stage (Fig. 3b ). Only 3 genes showed higher expression in early KS as compared to the advanced stages of the disease: angiopoietin 1 (ANGPT1), a pan-endothelial marker, VEGF and MMP2.
Lymphatic and blood endothelium signature by KS stage
Recently, LEC and BEC transcriptomes were reported, making it possible to dissect the LEC and BEC signature in various stages of KS (12, 14, 22) . Using the LEC and BEC marker genes enabled us to define the corresponding LEC and BEC gene signature in KS, as expressed by the different stages of the disease (Fig. 4) The KS transcriptome followed by stages of disease showed an extremely high expression of lymphatic markers including LYVE-1, Prox1, Angiopoietin 2, and Tie-2 (the receptor for angiopoietin 1, which also binds Angiopoietin 2 with similar affinity), podop1anin/TlA2, CD36, VEGF but also blood endothelial cell genes including CD34, (P<O.05) ( Fig. 1, Fig. 4 ).
RT-PCR
Although the mixed and nodular stages were mostly similar, there was still was a gradual increase in gene expression of selected genes from early to late disease. Among the LEC genes, LYVE-1 showed the highest increase in gene expression from early to nodular KS (Fig. 4, Fig. 5b ). The expression of other lymphatic genes including Prox-1, TlA-2 (podop1anin), angiopoietin 2 (a ligand for Tie-2), CD36, and IGF-1 was substantially elevated (Fig. 4) . 
NODULAR STAGE
Fig. 3. a) Protein expression ofHHV-8, LEC, MMPs. Immunohistochemistry including H&E and HHV8 immunostaining showing spindle cell and HHV-8 positive cells in early, mixed and nodular KS. Gradual increased protein expression of MMP I, MMP9 and CD206 from early to nodular disease was detected. b) Protein expression of dendritic and macrophage cell markers. Immunohistochemical staining in early and nodular KSfor CDIIc+ (myeloid dendritic cell marker)
and CDI63 (macrophage marker) which are highly distributed especially in early stage KS.
Fold Change
Gene Name Among the BEC genes, we found a striking increase in MHC class II expression (including HLA-DQBl, HLA-DRBl, HLA-DPA, and HLA-DMA) in the mixed and nodular stages of the disease, with no increased expression in early stage, compared to normal skin ( Fig. 4) . Of note is the fact that MHC class II expression was recently found to be a hallmark feature ofthe in vivo differentiation program of BEC (14) . Surprisingly, though CD34 and lCAMI were upregulated in the advanced stages, they were downregulated in the early stage of KS. In general, unlike the majority of the LEC genes that were upregulated in early KS when compared to normal skin, the majority of the BEC genes were actually down-regulated in early KS versus normal skin. This may imply that while LEC may be relatively more important in initiating the disease, BECs may potentially have an important role in the progression of the disease. The differential expression of LEC and BEC genes was further confirmed by RT-PCR ( Fig. 2) and immunohistochemistry (Fig. 3b, Fig. 5,  a,b,c) . Similarly to the genomic profile ( Fig. 1 and  4) , the mRNA expression ofLYVE-l, TlA-2/podoplanin and PROXI was highly up-regulated in advanced disease when compared to early stage and normal skin (Fig. 2) . In contrast, the mRNA expression of angiopoietin 2 and CD36 by RT-PCR was only slightly upregulated in the nodular stage of the KS. Interestingly, VEGF-C and IGF-I displayed a higher mRNA expression in the early stage than in the advanced stages of the disease, and all the KS stages showed a higher than normal mRNA expression. P values were significant for the comparison of nodular KS and normal skin and approaching significance for all other comparisons, potentially explained by the relatively low number of samples. Immunohistochemistry performed on early, mixed and nodular stage KS specimens showed positive staining of the LEC markers CD31, LYVE-l and Tie-2 (the receptor for angiopoietin 1, that also binds angiopoietin 2 with similar affinity) ( Fig. 6 ). Tie-2 staining intensity was particularly strong in nodular KS (Fig.3a ). Double immunofluorescence labelling showed a partial co-localization ofTie-2 with KSHV in both early and nodular KS (Fig. 5d ), compared to an almost complete co-localization of the lymphatic marker LYVE-I with KSHV in nodular KS and a partial co-localization of LYVE-I in early KS Fig. 5. a,b, ( Fig. 5e ). Because LYVE-l is almost completely coexpressed with KSHV in nodular stage, it may serve as a potential marker for KSHV infected cells in late stages of the disease.
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c) Increased protein expression of the LEC markers. Immunohistochemical staining in early and nodular KSfiJr LEC markers (LYVE-I, Tie-2 and CD3l) showing gradual increased protein expression from early to nodular disease. a) Double immunofluorescence labeling. Partial co-localization only ofthe lymphatic marker Tie-Z with HHV8 in both early and nodular KS, compared to an almost complete co-localization ofanother lymphatic marker LYVE-I with HHV-8 in nodular KS and a partial co-localization oj'LYVE-1 in early KS. b) Double immunofluorescence labeling. Single label staining is shown above each composite.
Matrix Metalloproteinases Induced by KS
Matrix metalloproteinases (MMPs) are critical molecules in cancer angiogenesis and metastasis (23, 24) . A number of MMPs were detected in KS cells, including MMP-I, 2, 3, 7, 9, 13, 14 and 19. This supports their roles in the pathogenesis of the disease (23) (24) (25) . To further investigate the role of MMPs in the initiation and progression ofKS, we analyzed the genomic differences in expression of the different MMPs by the stage of the disease (Fig. 6) .
In early KS, we found upregulation of MMP-2, MMP-13 and MMP-14, whereas MMP-l and MMP-9 were the prominent MMPs in mixed and nodular KS (Fig. 3a, Fig. 6 ). MMP-7 was downregulated in early and nodular disease, and only slightly elevated in mixed KS. Of note is the fact that MMP-2 expres-sion (in contrast to MMPI and 9) was previously detected in normal HUVEC cultures, but KSHV infection further increased its secretion at the early stage of infection only (23) . Our data supports a possible role for MMP-2 in the early stages of initiation of the disease, though its role in KSHV-induced cell invasion needs to be further elucidated. MMP-13 and MMP-14 may also playa role in the initiation of the disease (Fig. 6) . In contrast to MMP-2, MMP-9 production was not detected in normal HUVEC, and its expression was highly upregulated by KSHV infection, supporting transcriptional regulation by KSHV (23) . We found MMP-9 to be upregulated in all the stages of KS, with the highest expression in the advanced stages (39 and 17.8 fold change for mixed and nodular KS, respectively, compared to normal skin) ( Fig. 6 ).
DISCUSSION
Controversy surrounds the cellular origin of KS and the precise histogenesis of KS lesions, although it is known that KS tumors represent a complex interplay between cells from different lineages, including cells from the immune system and cells that harbor KSHV at different phases of infection (26) . In this study, we attempted to follow the progression of KS disease from early to late (nodular) stage, and to characterize the molecular fingerprinting of spindle cells and the inflammatory infiltrates associated with the different stages of the disease. We characterized "KS cluster" genes and followed the changes in their expression level by different stages of KS. In general, increased expression of"KS cluster" genes was observed from early to the nodular stage. In comparison to both normal skin and early KS, the mixed and nodular KS showed a dramatic increase in the expression of both LEC and immune-related genes. A similarity was found in gene expression of mixed and nodular stages, in accordance with the histologic difficulty in distinguishing between these stages. We observed an interesting trend of a gradual increase in the expression of LEC signature genes from early to nodular KS, whereas the expression of BEC signature genes was downregulated in the early stages of KS and upregulated in the more progressive stages. To the best of our knowledge our study is the first to demonstrate genomic evolution of a "KS signature" or KS transcriptome through different stages of the disease.
Furthermore, an abundance of cytokine and chemokine immune regulators was noticed in the gene signature of KS, particularly in the mixed and nodular stages. Cancer cells and de novo KSHV infected cells are known to express chemokine ligands and their corresponding receptors while their signaling is crucial for cell recruitment from the blood stream to specific tissues, and for tumor proliferation, migration, and angiogenesis (27, 28) . A significant increase in the transcription of three CXCR3 ligands, including CXCL-9, CXCL-I 0 and CXCL-II, was noticed. The expression of these ligands is known to be induced by interferon, and since they recruit inflammatory cells, they may playa role in the establishment and development of the lesions. The involvement of the CXCR4 ligand SDF-l in the recruitment of KSHV-infected cells from the circulation during the development of KS in the skin has been suggested (29) . However, down-regulation of the expression of CXCR4 upon infection of human vascular endothelial cells with KSHV has been recently reported and confirmed in KS lesions (30) . In line, KS spindle cells in AIDS-KS lesions did not express CXCR4, yet other cells in the lesions expressed CXCR4 (29, 31) . However, these studies did not provide clinical description of the KS lesions, and strong expression of CXCR4 in KS lesions has been reported in another study (31) .
Although the majority of the cells in the tumors are latently infected by KSHV, a small number of cells undergo lytic replication, releasing KSHVencoded paracrine factors and generating virions that spread to other cells, sustaining KS tumorigenesis (5) . Evidence supporting the necessity of lytic KSHV-infected cells for establishment and progression of KS has been reported by in vitro and in vivo models (32, 33) . The extensive expression of immune-, angiogenic and MMP-related genes in the nodular stage may reflect an increased fraction of cells undergoing lytic viral replication or enrichment in KSHV-infected spindle cells. Indeed, MMP induction could possibly contribute to KSHV cell invasion and play an important role in the propagation of the KS disease as supported by our data. This is in agreement with a recent report, indicating that the expression of MMP-l is regulated by KSHV at the transcriptional level (23) .
We also detected an up-regulated expression of angiopoietin 2 and Tie-2 that were suggested to have an important role in the pathogenesis of KS (26) . They were demonstrated to regulate the expression of inflammatory proteins in lymphatic endothelial cells, supporting a possible pivotal role in tumorassociated inflammation, angiogenesis and KSHVinfected endothelial cell proliferation (35, 36) . Increased angiopoietin 2 expression in tumors results in increased angiogenesis and tumor growth, whereas its inhibition has opposite effects (37, 38) . Angiopoietin 2 was recently shown to be highly expressed in KS tumors compared to a lack of its expression in normal skin (l0, 39). Angiopoietin 2 was reported to be up-regulated after KSHV infection, probably by MEKJMAPK activation (36, 40) .
In sum, our study demonstrates expression ofboth LEC and BEC markers in "KS expression signature" implying that KS spindle cells probably represent an indeterminate endothelial cell phenotype, possibly as a consequence of KSHV infection, although the LEC gene expression signature is much stronger. We observed an interesting trend of a gradual increase in the expression of LEC signature genes from early to nodular KS, whereas the expression ofBEC signature genes was downregulated in the early stages of KS and upregulated in the more progressive stages. This potentially suggests that while LEC genes might be involved in initiating the disease, BEC genes probably have an important role in disease progression.
